BUY CHAPTERS

Global Pharmacogenomics (PGx) Market Insights, Forecast to 2028

Q: How big is the Pharmacogenomics Market?

Ans. The global Pharmacogenomics (PGx) market size is projected to reach US$ 14590 million by 2028, from US$ 7757.9 million in 2021, at a CAGR of 9.3% during 2022-2028.

Q: Who are the key players available in the Pharmacogenomics Industry?

Ans. Some of the major companies are Abbott Laboratories, Affymetrix Inc, GeneDx, Assurex Health, Inc, Pfizer Inc, Rocheg, Thermo Fisher Scientific

Q: Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

Code: QYRE-Auto-22U5750

Report

January 2022

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Laboratory Corporation of America Holdings

Teva Pharmaceutical Industries Ltd

Thermo Fisher Scientific

Transgenomic

PCR

Pharmacogenomics Market

The global Pharmacogenomics (PGx) market size is projected to reach USD 14590 Million by 2028, from USD 7757.9 Million in 2021, at a CAGR of 9.3% during 2022-2028.

pharmacogenomics market

Fully considering the economic change by this health crisis, Polymerase Chain Reaction (PCR) accounting for % of the Pharmacogenomics (PGx) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Cardiovascular Diseases (CVD) segment is altered to an % CAGR throughout this forecast period.

China Pharmacogenomics (PGx) market size is valued at US$ million in 2021, while the North America and Europe Pharmacogenomics (PGx) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Pharmacogenomics (PGx) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacogenomics (PGx) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacogenomics (PGx) market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacogenomics (PGx) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacogenomics (PGx) market.

Pharmacogenomics (PGx) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics (PGx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other

By Application

Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other

By Company

Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Scope of Pharmacogenomics Market Report

Report Metric	Details
Report Name	Pharmacogenomics Market
The market size in 2021	USD 7757.9 Million
The revenue forecast in 2028	USD 14590 Million
Growth Rate	CAGR 9.3%
Market size available for years	2022-2028
Forecast units	Value (USD)
Segments covered	Type, Application, Industry, Regions
Report coverage	Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How big is the Pharmacogenomics Market?

Ans. The global Pharmacogenomics (PGx) market size is projected to reach US$ 14590 million by 2028, from US$ 7757.9 million in 2021, at a CAGR of 9.3% during 2022-2028.

2. Who are the key players available in the Pharmacogenomics Industry?

Ans. Some of the major companies are Abbott Laboratories, Affymetrix Inc, GeneDx, Assurex Health, Inc, Pfizer Inc, Rocheg, Thermo Fisher Scientific

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Polymerase Chain Reaction (PCR)

1.2.3 Microarray

1.2.4 Sequencing

1.2.5 Other

1.3 Market by Application

1.3.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Cardiovascular Diseases (CVD)

1.3.3 Central Nervous System (CNS)

1.3.4 Cancer/Oncology

1.3.5 Infectious Diseases

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Pharmacogenomics (PGx) Market Perspective (2017-2028)

2.2 Pharmacogenomics (PGx) Growth Trends by Region

2.2.1 Pharmacogenomics (PGx) Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Pharmacogenomics (PGx) Historic Market Size by Region (2017-2022)

2.2.3 Pharmacogenomics (PGx) Forecasted Market Size by Region (2023-2028)

2.3 Pharmacogenomics (PGx) Market Dynamics

2.3.1 Pharmacogenomics (PGx) Industry Trends

2.3.2 Pharmacogenomics (PGx) Market Drivers

2.3.3 Pharmacogenomics (PGx) Market Challenges

2.3.4 Pharmacogenomics (PGx) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacogenomics (PGx) Players by Revenue

3.1.1 Global Top Pharmacogenomics (PGx) Players by Revenue (2017-2022)

3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2017-2022)

3.2 Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue

3.4 Global Pharmacogenomics (PGx) Market Concentration Ratio

3.4.1 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics (PGx) Revenue in 2021

3.5 Pharmacogenomics (PGx) Key Players Head office and Area Served

3.6 Key Players Pharmacogenomics (PGx) Product Solution and Service

3.7 Date of Enter into Pharmacogenomics (PGx) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacogenomics (PGx) Breakdown Data by Type

4.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2017-2022)

4.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2023-2028)

5 Pharmacogenomics (PGx) Breakdown Data by Application

5.1 Global Pharmacogenomics (PGx) Historic Market Size by Application (2017-2022)

5.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Pharmacogenomics (PGx) Market Size (2017-2028)

6.2 North America Pharmacogenomics (PGx) Market Size by Type

6.2.1 North America Pharmacogenomics (PGx) Market Size by Type (2017-2022)

6.2.2 North America Pharmacogenomics (PGx) Market Size by Type (2023-2028)

6.2.3 North America Pharmacogenomics (PGx) Market Share by Type (2017-2028)

6.3 North America Pharmacogenomics (PGx) Market Size by Application

6.3.1 North America Pharmacogenomics (PGx) Market Size by Application (2017-2022)

6.3.2 North America Pharmacogenomics (PGx) Market Size by Application (2023-2028)

6.3.3 North America Pharmacogenomics (PGx) Market Share by Application (2017-2028)

6.4 North America Pharmacogenomics (PGx) Market Size by Country

6.4.1 North America Pharmacogenomics (PGx) Market Size by Country (2017-2022)

6.4.2 North America Pharmacogenomics (PGx) Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Pharmacogenomics (PGx) Market Size (2017-2028)

7.2 Europe Pharmacogenomics (PGx) Market Size by Type

7.2.1 Europe Pharmacogenomics (PGx) Market Size by Type (2017-2022)

7.2.2 Europe Pharmacogenomics (PGx) Market Size by Type (2023-2028)

7.2.3 Europe Pharmacogenomics (PGx) Market Share by Type (2017-2028)

7.3 Europe Pharmacogenomics (PGx) Market Size by Application

7.3.1 Europe Pharmacogenomics (PGx) Market Size by Application (2017-2022)

7.3.2 Europe Pharmacogenomics (PGx) Market Size by Application (2023-2028)

7.3.3 Europe Pharmacogenomics (PGx) Market Share by Application (2017-2028)

7.4 Europe Pharmacogenomics (PGx) Market Size by Country

7.4.1 Europe Pharmacogenomics (PGx) Market Size by Country (2017-2022)

7.4.2 Europe Pharmacogenomics (PGx) Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmacogenomics (PGx) Market Size (2017-2028)

8.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type

8.2.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Pharmacogenomics (PGx) Market Share by Type (2017-2028)

8.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application

8.3.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Pharmacogenomics (PGx) Market Share by Application (2017-2028)

8.4 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region

8.4.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Pharmacogenomics (PGx) Market Size (2017-2028)

9.2 Latin America Pharmacogenomics (PGx) Market Size by Type

9.2.1 Latin America Pharmacogenomics (PGx) Market Size by Type (2017-2022)

9.2.2 Latin America Pharmacogenomics (PGx) Market Size by Type (2023-2028)

9.2.3 Latin America Pharmacogenomics (PGx) Market Share by Type (2017-2028)

9.3 Latin America Pharmacogenomics (PGx) Market Size by Application

9.3.1 Latin America Pharmacogenomics (PGx) Market Size by Application (2017-2022)

9.3.2 Latin America Pharmacogenomics (PGx) Market Size by Application (2023-2028)

9.3.3 Latin America Pharmacogenomics (PGx) Market Share by Application (2017-2028)

9.4 Latin America Pharmacogenomics (PGx) Market Size by Country

9.4.1 Latin America Pharmacogenomics (PGx) Market Size by Country (2017-2022)

9.4.2 Latin America Pharmacogenomics (PGx) Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacogenomics (PGx) Market Size (2017-2028)

10.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type

10.2.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Pharmacogenomics (PGx) Market Share by Type (2017-2028)

10.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application

10.3.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Pharmacogenomics (PGx) Market Share by Application (2017-2028)

10.4 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country

10.4.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Introduction

11.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.1.5 Abbott Laboratories Recent Developments

11.2 Affymetrix, Inc.

11.2.1 Affymetrix, Inc. Company Details

11.2.2 Affymetrix, Inc. Business Overview

11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Introduction

11.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.2.5 Affymetrix, Inc. Recent Developments

11.3 Assurex Health, Inc

11.3.1 Assurex Health, Inc Company Details

11.3.2 Assurex Health, Inc Business Overview

11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Introduction

11.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.3.5 Assurex Health, Inc Recent Developments

11.4 Astrazeneca

11.4.1 Astrazeneca Company Details

11.4.2 Astrazeneca Business Overview

11.4.3 Astrazeneca Pharmacogenomics (PGx) Introduction

11.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.4.5 Astrazeneca Recent Developments

11.5 GeneDX

11.5.1 GeneDX Company Details

11.5.2 GeneDX Business Overview

11.5.3 GeneDX Pharmacogenomics (PGx) Introduction

11.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.5.5 GeneDX Recent Developments

11.6 Illumina, Inc.

11.6.1 Illumina, Inc. Company Details

11.6.2 Illumina, Inc. Business Overview

11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Introduction

11.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.6.5 Illumina, Inc. Recent Developments

11.7 Laboratory Corporation of America Holdings

11.7.1 Laboratory Corporation of America Holdings Company Details

11.7.2 Laboratory Corporation of America Holdings Business Overview

11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Introduction

11.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.7.5 Laboratory Corporation of America Holdings Recent Developments

11.8 Myriad Genetics, Inc.

11.8.1 Myriad Genetics, Inc. Company Details

11.8.2 Myriad Genetics, Inc. Business Overview

11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Introduction

11.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.8.5 Myriad Genetics, Inc. Recent Developments

11.9 Pathway Genomics

11.9.1 Pathway Genomics Company Details

11.9.2 Pathway Genomics Business Overview

11.9.3 Pathway Genomics Pharmacogenomics (PGx) Introduction

11.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.9.5 Pathway Genomics Recent Developments

11.10 Pfizer, Inc

11.10.1 Pfizer, Inc Company Details

11.10.2 Pfizer, Inc Business Overview

11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Introduction

11.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.10.5 Pfizer, Inc Recent Developments

11.11 Qiagen, Inc.

11.11.1 Qiagen, Inc. Company Details

11.11.2 Qiagen, Inc. Business Overview

11.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Introduction

11.11.4 Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.11.5 Qiagen, Inc. Recent Developments

11.12 Rocheg

11.12.1 Rocheg Company Details

11.12.2 Rocheg Business Overview

11.12.3 Rocheg Pharmacogenomics (PGx) Introduction

11.12.4 Rocheg Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.12.5 Rocheg Recent Developments

11.13 Teva Pharmaceutical Industries Ltd.

11.13.1 Teva Pharmaceutical Industries Ltd. Company Details

11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Introduction

11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments

11.14 Thermo Fisher Scientific

11.14.1 Thermo Fisher Scientific Company Details

11.14.2 Thermo Fisher Scientific Business Overview

11.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Introduction

11.14.4 Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.14.5 Thermo Fisher Scientific Recent Developments

11.15 Transgenomic, Inc.

11.15.1 Transgenomic, Inc. Company Details

11.15.2 Transgenomic, Inc. Business Overview

11.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Introduction

11.15.4 Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)

11.15.5 Transgenomic, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Laboratory Corporation of America Holdings

Teva Pharmaceutical Industries Ltd

Thermo Fisher Scientific

Transgenomic

PCR

List of Tables

Table 1. Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Polymerase Chain Reaction (PCR)

Table 3. Key Players of Microarray

Table 4. Key Players of Sequencing

Table 5. Key Players of Other

Table 6. Global Pharmacogenomics (PGx) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global Pharmacogenomics (PGx) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 8. Global Pharmacogenomics (PGx) Market Size by Region (2017-2022) & (US$ Million)

Table 9. Global Pharmacogenomics (PGx) Market Share by Region (2017-2022)

Table 10. Global Pharmacogenomics (PGx) Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 11. Global Pharmacogenomics (PGx) Market Share by Region (2023-2028)

Table 12. Pharmacogenomics (PGx) Market Trends

Table 13. Pharmacogenomics (PGx) Market Drivers

Table 14. Pharmacogenomics (PGx) Market Challenges

Table 15. Pharmacogenomics (PGx) Market Restraints

Table 16. Global Pharmacogenomics (PGx) Revenue by Players (2017-2022) & (US$ Million)

Table 17. Global Pharmacogenomics (PGx) Revenue Share by Players (2017-2022)

Table 18. Global Top Pharmacogenomics (PGx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2021)

Table 19. Ranking of Global Top Pharmacogenomics (PGx) Companies by Revenue (US$ Million) in 2021

Table 20. Global 5 Largest Players Market Share by Pharmacogenomics (PGx) Revenue (CR5 and HHI) & (2017-2022)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Pharmacogenomics (PGx) Product Solution and Service

Table 23. Date of Enter into Pharmacogenomics (PGx) Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)

Table 26. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2017-2022)

Table 27. Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 28. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2023-2028)

Table 29. Global Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)

Table 30. Global Pharmacogenomics (PGx) Revenue Share by Application (2017-2022)

Table 31. Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 32. Global Pharmacogenomics (PGx) Revenue Share by Application (2023-2028)

Table 33. North America Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)

Table 34. North America Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)

Table 35. North America Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)

Table 36. North America Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)

Table 37. North America Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)

Table 38. North America Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)

Table 39. Europe Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)

Table 40. Europe Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)

Table 41. Europe Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)

Table 42. Europe Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)

Table 43. Europe Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)

Table 44. Europe Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)

Table 45. Asia Pacific Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)

Table 46. Asia Pacific Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)

Table 47. Asia Pacific Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)

Table 48. Asia Pacific Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)

Table 49. Asia Pacific Pharmacogenomics (PGx) Market Size by Region (2017-2022) & (US$ Million)

Table 50. Asia Pacific Pharmacogenomics (PGx) Market Size by Region (2023-2028) & (US$ Million)

Table 51. Latin America Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)

Table 52. Latin America Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)

Table 53. Latin America Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)

Table 54. Latin America Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)

Table 55. Latin America Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)

Table 56. Latin America Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)

Table 63. Abbott Laboratories Company Details

Table 64. Abbott Laboratories Business Overview

Table 65. Abbott Laboratories Pharmacogenomics (PGx) Product

Table 66. Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 67. Abbott Laboratories Recent Developments

Table 68. Affymetrix, Inc. Company Details

Table 69. Affymetrix, Inc. Business Overview

Table 70. Affymetrix, Inc. Pharmacogenomics (PGx) Product

Table 71. Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 72. Affymetrix, Inc. Recent Developments

Table 73. Assurex Health, Inc Company Details

Table 74. Assurex Health, Inc Business Overview

Table 75. Assurex Health, Inc Pharmacogenomics (PGx) Product

Table 76. Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 77. Assurex Health, Inc Recent Developments

Table 78. Astrazeneca Company Details

Table 79. Astrazeneca Business Overview

Table 80. Astrazeneca Pharmacogenomics (PGx) Product

Table 81. Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 82. Astrazeneca Recent Developments

Table 83. GeneDX Company Details

Table 84. GeneDX Business Overview

Table 85. GeneDX Pharmacogenomics (PGx) Product

Table 86. GeneDX Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 87. GeneDX Recent Developments

Table 88. Illumina, Inc. Company Details

Table 89. Illumina, Inc. Business Overview

Table 90. Illumina, Inc. Pharmacogenomics (PGx) Product

Table 91. Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 92. Illumina, Inc. Recent Developments

Table 93. Laboratory Corporation of America Holdings Company Details

Table 94. Laboratory Corporation of America Holdings Business Overview

Table 95. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product

Table 96. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 97. Laboratory Corporation of America Holdings Recent Developments

Table 98. Myriad Genetics, Inc. Company Details

Table 99. Myriad Genetics, Inc. Business Overview

Table 100. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product

Table 101. Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 102. Myriad Genetics, Inc. Recent Developments

Table 103. Pathway Genomics Company Details

Table 104. Pathway Genomics Business Overview

Table 105. Pathway Genomics Pharmacogenomics (PGx) Product

Table 106. Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 107. Pathway Genomics Recent Developments

Table 108. Pfizer, Inc Company Details

Table 109. Pfizer, Inc Business Overview

Table 110. Pfizer, Inc Pharmacogenomics (PGx) Product

Table 111. Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 112. Pfizer, Inc Recent Developments

Table 113. Qiagen, Inc. Company Details

Table 114. Qiagen, Inc. Business Overview

Table 115. Qiagen, Inc. Pharmacogenomics (PGx) Product

Table 116. Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 117. Qiagen, Inc. Recent Developments

Table 118. Rocheg Company Details

Table 119. Rocheg Business Overview

Table 120. Rocheg Pharmacogenomics (PGx) Product

Table 121. Rocheg Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 122. Rocheg Recent Developments

Table 123. Teva Pharmaceutical Industries Ltd. Company Details

Table 124. Teva Pharmaceutical Industries Ltd. Business Overview

Table 125. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product

Table 126. Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 127. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 128. Thermo Fisher Scientific Company Details

Table 129. Thermo Fisher Scientific Business Overview

Table 130. Thermo Fisher Scientific Pharmacogenomics (PGx) Product

Table 131. Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 132. Thermo Fisher Scientific Recent Developments

Table 133. Transgenomic, Inc. Company Details

Table 134. Transgenomic, Inc. Business Overview

Table 135. Transgenomic, Inc. Pharmacogenomics (PGx) Product

Table 136. Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)

Table 137. Transgenomic, Inc. Recent Developments

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmacogenomics (PGx) Market Share by Type: 2021 VS 2028

Figure 2. Polymerase Chain Reaction (PCR) Features

Figure 3. Microarray Features

Figure 4. Sequencing Features

Figure 5. Other Features

Figure 6. Global Pharmacogenomics (PGx) Market Share by Application: 2021 VS 2028

Figure 7. Cardiovascular Diseases (CVD) Case Studies

Figure 8. Central Nervous System (CNS) Case Studies

Figure 9. Cancer/Oncology Case Studies

Figure 10. Infectious Diseases Case Studies

Figure 11. Other Case Studies

Figure 12. Pharmacogenomics (PGx) Report Years Considered

Figure 13. Global Pharmacogenomics (PGx) Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 14. Global Pharmacogenomics (PGx) Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 15. Global Pharmacogenomics (PGx) Market Share by Region: 2021 VS 2028

Figure 16. Global Pharmacogenomics (PGx) Market Share by Players in 2021

Figure 17. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2021)

Figure 18. The Top 10 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2021

Figure 19. North America Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)

Figure 20. North America Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)

Figure 21. North America Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)

Figure 22. North America Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)

Figure 23. United States Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Canada Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Europe Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)

Figure 26. Europe Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)

Figure 27. Europe Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)

Figure 28. Europe Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)

Figure 29. Germany Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. France Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. U.K. Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Italy Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Russia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Nordic Countries Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Asia-Pacific Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)

Figure 36. Asia Pacific Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)

Figure 37. Asia Pacific Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)

Figure 38. Asia Pacific Pharmacogenomics (PGx) Market Size Share by Region (2017-2028)

Figure 39. China Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Japan Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. South Korea Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Southeast Asia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. India Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. Australia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 45. Latin America Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)

Figure 46. Latin America Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)

Figure 47. Latin America Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)

Figure 48. Latin America Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)

Figure 49. Mexico Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Brazil Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 51. Middle East & Africa Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)

Figure 52. Middle East and Africa Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)

Figure 53. Middle East and Africa Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)

Figure 54. Middle East and Africa Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)

Figure 55. Turkey Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Saudi Arabia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. UAE Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 58. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 59. Affymetrix, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 60. Assurex Health, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 61. Astrazeneca Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 62. GeneDX Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 63. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 64. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 65. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 66. Pathway Genomics Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 67. Pfizer, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 68. Qiagen, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 69. Rocheg Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 70. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 72. Transgenomic, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmacogenomics (PGx) Market Insights, Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-22U5750

Global Pharmacogenomics (PGx) Market Insights, Forecast to 2028

FEATURED COMPANIES

Pharmacogenomics Market

By Type

By Application

By Company

By Region

Scope of Pharmacogenomics Market Report

Frequently Asked Questions About This Report

1. How big is the Pharmacogenomics Market?

2. Who are the key players available in the Pharmacogenomics Industry?

3. Does the report provides covid-19 impact analysis?

FEATURED COMPANIES

RELATED REPORTS